Chronic Kidney Disease

Cynthia Delgado, MD, received the Garabed Eknoyan Award for her guidance in removing race as a factor for diagnosing chronic kidney disease at the National Kidney Foundation Spring Clinical Meetings.

AUSTIN, Texas — In this video, Kerry Cooper, MD, discusses the potential Renal Autologous Cell Therapy by ProKidney may have to preserve kidney function and slow the progression of kidney disease.

Lois Hill, MS, RDN, LD, LDE, dietician nutritionist and educator, was honored with the Joel D. Kopple Award at the National Kidney Foundation Spring Clinical Meetings, according to a press release.

Parathyroidectomy had no significant impact on long-term kidney function among older adults with primary hyperparathyroidism, but if done early, it could preserve function in those aged younger than 60, according to researchers.

More than 5 million patient charts have been entered into the Acumen Epic Connect platform, according to press release.

Treating patients with chronic kidney disease and hyperkalemia with patiromer reduced serum phosphorus and serum potassium levels during a 2-week period, according to data published in the American Journal of Kidney Diseases.

Researchers identified a test-negative design as the “least biased and most efficient” to measure COVID-19 vaccine effectiveness in patients with chronic kidney disease, according to data in Kidney International.

Over time, a declining hemoglobin z score correlates with impaired height among children with mild to moderate nonglomerular chronic kidney disease, according to data published in the American Journal of Kidney Diseases.

Chronic kidney disease occurs commonly in patients with hypertension and diabetes, and is also associated with acute kidney failure, intrinsic kidney disorders and family history of chronic kidney disease.

Compared with glucagon-like peptide-1 receptor agonists, patients with chronic kidney disease and type 2 diabetes experienced increased risks when taking SGLT2 inhibitors, according to published data.